4 ms·
Can you elaborate? In particular, this: >>>>Five-year data indicate a significant progression-free survival benefit, with 60% of patients free of progression.
by IG_Semmelweiss 2y ago
Can you elaborate? In particular, this:
>>>>Five-year data indicate a significant progression-free survival benefit, with 60% of patients free of progression.
So far im with you.
>>>>Even after 60.2 months of follow-up, the median progression-free survival has not yet been reached [1]
This sounds awful? Or contradictory at best?
- ilya_m 2y ago>>>>Even after 60.2 months of follow-up, the median progression-free survival has not yet been reached [1] > This sounds awful? Or contradictory at best? No, quite amazing. At 5 years more than 50% of participants are progression-free. That's indeed off the charts for a metastatic lung cancer.
- fredophile 2y agoI believe the median progression-free survival is the length of time where 50% of people are still free from progression. The numbers you mentioned would mean that we don't know how long that is for this treatment but it's definitely longer than 5 years. That sounds pretty good depending on the type of cancer and stage when treatment started.
- deleted 2y ago[deleted]